NEWS
GBIP Canada Application Success
Atelerix has been awarded a place on the Global Business Innovation Programme for Biomanufacturing of Biologics and Advanced Therapies in Canada. Organised by Innovate UK and delivered by Innovate UK...
GBIP Canada Application Success
Atelerix has been awarded a place on the Global Business Innovation Programme for Biomanufacturing of Biologics and Advanced Therapies in Canada. Organised by Innovate UK and delivered by Innovate UK...
Press Release: Strategic partnership for market...
Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells, tissues, and viruses at hypothermic temperature (without freezing) is pleased to announce they have signed...
Press Release: Strategic partnership for market...
Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells, tissues, and viruses at hypothermic temperature (without freezing) is pleased to announce they have signed...
New Publication Announcement!
Following on from LVPEI's successful proof of concept studies highlighting the successful use of Atelerix's technology to distribute a limbal-stromal cell therapy throughout India (Damala et al., 2019), we are delighted to announce the...
New Publication Announcement!
Following on from LVPEI's successful proof of concept studies highlighting the successful use of Atelerix's technology to distribute a limbal-stromal cell therapy throughout India (Damala et al., 2019), we are delighted to announce the...
CytoStor™ successfully preserves primary human ...
The liver microenvironment is proving to be a major obstacle to the success of immunotherapy in solid organ tumours. The liver is characterised by tolerogenic properties that lead to the...
CytoStor™ successfully preserves primary human ...
The liver microenvironment is proving to be a major obstacle to the success of immunotherapy in solid organ tumours. The liver is characterised by tolerogenic properties that lead to the...
Atelerix presents promising data for the applic...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched...
Atelerix presents promising data for the applic...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched...
New Publication Announcement!
Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived Mesenchymal Stromal Cells. Demonstrating the maintenance of MSC viability and...
New Publication Announcement!
Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived Mesenchymal Stromal Cells. Demonstrating the maintenance of MSC viability and...
